- Report
- June 2025
- 200 Pages
Global
From €2443EUR$2,789USD£2,120GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2443EUR$2,789USD£2,120GBP
- Report
- January 2026
- 291 Pages
Global
From €2190EUR$2,500USD£1,900GBP
- Report
- June 2025
- 400 Pages
Global
From €4334EUR$4,949USD£3,762GBP
- Report
- November 2025
- 150 Pages
Global
From €3372EUR$3,850USD£2,927GBP
€4248EUR$4,850USD£3,687GBP
- Report
- November 2025
- 150 Pages
Global
From €3372EUR$3,850USD£2,927GBP
€4248EUR$4,850USD£3,687GBP
- Report
- February 2025
- 150 Pages
Global
From €3372EUR$3,850USD£2,927GBP
€4248EUR$4,850USD£3,687GBP
- Report
- June 2025
- 76 Pages
Global
From €3500EUR$4,281USD£3,144GBP
- Report
- November 2025
- 160 Pages
Global
From €3459EUR$3,950USD£3,003GBP
- Report
- October 2025
- 160 Pages
Global
From €3459EUR$3,950USD£3,003GBP
- Report
- October 2025
- 160 Pages
Global
From €3459EUR$3,950USD£3,003GBP
- Report
- October 2025
- 160 Pages
Global
From €3459EUR$3,950USD£3,003GBP
- Report
- October 2025
- 160 Pages
Global
From €3459EUR$3,950USD£3,003GBP
- Report
- August 2025
- 150 Pages
Global
From €3459EUR$3,950USD£3,003GBP
- Report
- May 2025
- 150 Pages
Global
From €3372EUR$3,850USD£2,927GBP
€4248EUR$4,850USD£3,687GBP
- Report
- April 2025
- 140 Pages
Global
From €4248EUR$4,850USD£3,687GBP
- Report
- January 2019
- 144 Pages
Global
From €2409EUR$2,750USD£2,090GBP
- Report
- August 2023
- 230 Pages
Global
From €2146EUR$2,450USD£1,862GBP
- Report
- March 2024
- 200 Pages
Global
From €3635EUR$4,150USD£3,155GBP
- Report
- January 2025
- 175 Pages
Global
From €3932EUR$4,490USD£3,413GBP

The Antihypertensive market is a subset of the Cardiovascular Drugs market, which focuses on medications used to treat high blood pressure. These drugs are used to reduce the risk of stroke, heart attack, and other cardiovascular diseases. Antihypertensives work by blocking the action of certain hormones, such as angiotensin II, which cause blood vessels to constrict. Common classes of antihypertensives include diuretics, beta blockers, ACE inhibitors, calcium channel blockers, and angiotensin receptor blockers.
The Antihypertensive market is highly competitive, with many large pharmaceutical companies offering a variety of products. Some of the major players in the market include Pfizer, Novartis, Merck, Sanofi, and GlaxoSmithKline. Other companies, such as AstraZeneca, Boehringer Ingelheim, and Daiichi Sankyo, also offer antihypertensive medications. Show Less Read more